SIGLEC9 and neoplasm: It has been found that tumor cells can express sialylated ligands for SIGLEC receptors on immune cells, depressing immune cell function to escape immune surveillance, such as SIGLEC7 and SIGLEC9 on natural killer cell (7–12).